13F Filings History of Cypress Capital Management LLC (WY)

Latest 13F report
Q4 2025 - 09 Feb 2026
Value $
$107,672,982
Signature - Title
Denise Ebzery - Chief Compliance Officer
Location
Sheridan, WY
Summary
This page shows a list of all the recent 13F filings made by Cypress Capital Management LLC (WY). Form 13F is required to be filed within 45 days of the end of a calendar quarter. Cypress Capital Management LLC (WY) reported 207 stock holdings with total value $107,672,982 as of Q4 2025. Top holdings included AAPL, QQQX, ETY, YDESW, and BGR.

Notify me when Cypress Capital Management LLC (WY) files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 207 $107,672,982 +$5,954,171 -$4,704,678 +$1,249,493 AAPL, QQQX, ETY, YDESW, BGR 13F-HR 09 Feb 2026, 16:37
Q3 2025 179 $108,398,775 +$12,398,842 -$5,191,992 +$7,206,850 AAPL, YDESW, QQQX, ETY, COST 13F-HR 03 Nov 2025, 11:08
Q2 2025 173 $92,118,036 +$12,321,760 -$7,862,112 +$4,459,648 AAPL, COST, QQQX, ETY, BGR 13F-HR 06 Aug 2025, 19:17
Q1 2025 162 $83,685,609 +$6,790,948 -$11,094,019 -$4,303,071 AAPL, COST, AGI, PM, FIBK 13F-HR 05 May 2025, 11:25
Q4 2024 150 $87,350,923 +$9,545,893 -$12,645,024 -$3,099,131 AAPL, COST, FIBK, IJT, AMLP 13F-HR 23 Jan 2025, 15:31
Q3 2024 162 $92,461,027 +$8,097,008 -$15,282,537 -$7,185,529 AAPL, COST, GLD, GDX, FIBK 13F-HR 05 Nov 2024, 10:47
Q2 2024 166 $93,860,891 +$8,804,561 -$10,581,524 -$1,776,963 AAPL, COST, GLD, GDX, FIBK 13F-HR 05 Aug 2024, 13:23
Q1 2024 170 $93,756,843 +$17,776,290 -$16,915,046 +$861,244 AAPL, TLT, GLD, COST, FIBK 13F-HR 09 May 2024, 12:10
Q4 2023 172 $91,251,033 +$6,296,020 -$7,176,365 -$880,345 AAPL, TLT, FIBK, GLD, COST 13F-HR 05 Feb 2024, 15:48
Q3 2023 179 $85,101,157 +$5,002,221 -$3,009,548 +$1,992,673 AAPL, TLT, GLD, BNDD, COST 13F-HR 13 Nov 2023, 14:08
Q2 2023 172 $89,360,343 +$8,051,575 -$5,874,960 +$2,176,615 AAPL, TLT, BNDD, GLD, SHY 13F-HR 01 Aug 2023, 09:00
Q1 2023 163 $85,447,475 +$9,122,638 -$6,332,652 +$2,789,986 AAPL, TLT, GLD, FIBK, SHY 13F-HR 10 May 2023, 12:02
Q4 2022 163 $76,435,132 +$12,576,040 -$4,264,664 +$8,311,376 AAPL, FIBK, TLT, SHY, GLD 13F-HR 02 Feb 2023, 16:53
Q3 2022 154 $70,302,000 +$2,503,085 -$8,154,784 -$5,651,699 AAPL, FIBK, TLT, BNDD, SHY 13F-HR 14 Nov 2022, 09:00
Q2 2022 164 $77,365,000 +$19,649,849 -$14,035,166 +$5,614,683 AAPL, TLT, FIBK, BNDD, SHY 13F-HR 01 Aug 2022, 14:54
Q1 2022 169 $84,383,000 +$26,372,367 -$57,248,703 -$30,876,336 AAPL, TLT, BNDD, FIBK, GLD 13F-HR 09 May 2022, 14:02
Q4 2021 274 $119,157,000 +$40,890,061 -$42,941,240 -$2,051,179 AAPL, FIBK, ITB, XLK, FNGS 13F-HR 11 Feb 2022, 10:45
Q3 2021 237 $120,602,000 +$25,883,049 -$31,238,566 -$5,355,517 AAPL, FIBK, GDX, XLV, FNGS 13F-HR 04 Nov 2021, 11:33
Q2 2021 292 $129,204,000 +$31,429,595 -$22,489,597 +$8,939,998 AAPL, FIBK, GDX, AMD, DCP 13F-HR 10 Aug 2021, 11:53
Q1 2021 280 $113,450,000 +$31,625,080 -$37,771,854 -$6,146,774 AAPL, FIBK, GDX, XLV, AMZN 13F-HR 07 May 2021, 12:54
Q4 2020 222 $114,194,000 +$26,875,175 -$29,965,126 -$3,089,951 AAPL, FIBK, GDX, XSD, EW 13F-HR 29 Jan 2021, 14:33
Q3 2020 202 $110,535,000 +$21,915,773 -$14,840,651 +$7,075,122 AAPL, FIBK, EW, GDX, KL 13F-HR 28 Oct 2020, 15:19
Q2 2020 192 $99,348,000 +$24,963,838 -$9,875,442 +$15,088,396 AAPL, FIBK, EW, GDX, PFF 13F-HR 11 Aug 2020, 12:04
Q1 2020 176 $65,621,000 +$6,490,056 -$15,834,732 -$9,344,676 AAPL, EW, PFF, GDX, XLV 13F-HR 06 May 2020, 16:09
Q4 2019 182 $105,965,000 +$42,256,512 -$26,684,128 +$15,572,384 FIBK, AAPL, EW, GDX, KL 13F-HR 03 Feb 2020, 14:09
Q3 2019 192 $85,094,000 +$18,563,730 -$18,953,734 -$390,004 AAPL, EDWARDS LIFESCIENCES CORP, CARA THERAPEUTICS INC, KL, GDX 13F-HR 12 Nov 2019, 11:02
Q2 2019 256 $83,736,000 +$22,893,070 -$15,229,394 +$7,663,676 EDWARDS LIFESCIENCES CORP, AAPL, CARA THERAPEUTICS INC, XLV, STZ 13F-HR 12 Aug 2019, 12:42
Q1 2019 268 $74,768,000 +$26,408,939 -$11,201,445 +$15,207,494 EDWARDS LIFESCIENCES CORP, AAPL, XLV, TLT, CARA THERAPEUTICS INC 13F-HR 06 May 2019, 15:27
Q4 2018 327 $51,964,000 +$3,519,444 -$34,267,414 -$30,747,970 AAPL, EDWARDS LIFESCIENCES CORP, XLV, PFF, XLK 13F-HR 05 Feb 2019, 12:26
Q3 2018 338 $99,012,000 +$16,709,521 -$15,716,662 +$992,859 AAPL, SCHX, NVDA, SCHM, XLV 13F-HR 31 Oct 2018, 13:39
Q2 2018 319 $95,329,000 +$18,762,283 -$11,112,424 +$7,649,859 AAPL, SCHX, NVDA, MU, SCHM 13F-HR 08 Aug 2018, 12:13
Q1 2018 300 $87,158,000 +$20,136,900 -$18,130,933 +$2,005,967 AAPL, MO, SCHX, NVDA, SCHM 13F-HR 03 May 2018, 13:30
Q4 2017 302 $87,904,000 +$11,512,022 -$10,910,187 +$601,835 MO, AAPL, CELG, VGR, NVDA 13F-HR 31 Jan 2018, 10:58
Q3 2017 266 $84,533,000 +$17,412,327 -$21,919,461 -$4,507,134 MO, CELG, AAPL, BTI, NVDA 13F-HR 07 Nov 2017, 14:27
Q2 2017 267 $87,222,269 +$12,412,820 -$7,334,127 +$5,078,693 MO, CELG, RAI, FIBK, AAPL 13F-HR 19 Jul 2017, 12:33
Q1 2017 267 $80,807,249 +$7,082,877 -$14,582,499 -$7,499,622 MO, CELG, RAI, FIBK, AAPL 13F-HR 19 Apr 2017, 16:05
Q4 2016 258 $82,546,593 +$11,063,827 -$9,879,551 +$1,184,276 MO, CELG, RAI, FIBK, AAPL 13F-HR 17 Jan 2017, 13:03
Q3 2016 236 $78,125,638 +$6,365,477 -$2,874,459 +$3,491,018 MO, CELG, RAI, FIBK, AAPL 13F-HR 07 Nov 2016, 15:33
Q2 2016 224 $76,411,615 +$15,126,419 -$12,330,932 +$2,795,487 MO, RAI, CELG, CORE, FIBK 13F-HR 28 Jul 2016, 15:28
Q1 2016 202 $74,080,430 +$4,922,075 -$9,682,270 -$4,760,195 MO, CELG, RAI, AAPL, FIBK 13F-HR 28 Apr 2016, 16:50
Q4 2015 233 $79,461,353 +$436,219 -$152,213 +$284,006 MO, CELG, RAI, CORE, FIBK 13F-HR 01 Feb 2016, 12:48
Q3 2015 233 $77,815,925 +$8,257,596 -$10,510,039 -$2,252,443 MO, CELG, RAI, AAPL, FIBK 13F-HR 22 Oct 2015, 15:58
Q2 2015 260 $88,428,990 +$11,546,365 -$4,826,531 +$6,719,834 MO, CELG, AAPL, GILD, RAI 13F-HR 29 Jul 2015, 13:43
Q1 2015 242 $81,641,368 +$8,900,639 -$6,405,565 +$2,495,074 MO, CELG, AAPL, RAI, GILD 13F-HR 05 May 2015, 10:45
Q4 2014 248 $76,979,045 $0 $0 $0 MO, CELG, AAPL, PM, RAI 13F-HR 17 Feb 2015, 14:26